Adrenomed

Hennigsdorf, Germany · Founded 2009 · Privately Held (backing)

Developer of clinical-stage pharmaceutical products designed to improve vascular integrity. Adrenomed is based in Hennigsdorf, Germany and was founded in 2009. Its last reported valuation was $134 million in Mar 2021. It has raised $61.3 million.

Last reported valuation

$133.9M

Oct 2026

Priced at

—

Total raised

$61.3M

Last round

—

How much has Adrenomed raised?

$61.3Macross 0 recorded rounds

Free account

More of Adrenomed with a free account

·Watch Adrenomed: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Adrenomed investors

10 investors are on record for Adrenomed, including VU Venture Partners, Brandenburg Kapital, HBM Partners and Wellington Partners.

For fundraisers

Raising for a company like Adrenomed?

10 investors have backed Adrenomed.

See all 10 investors →

Frequently asked about Adrenomed

How much has Adrenomed raised?: Adrenomed has raised $61.3M in total across 0 recorded funding rounds.